RLVSX | RTECX | RLVSX / RTECX | |
Total Expense Ratio | 0.51 | 1.51 | 34% |
Annual Report Gross Expense Ratio | 0.57 | 1.57 | 36% |
Fund Existence | 40 years | 26 years | - |
Gain YTD | 0.093 | -0.515 | -18% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.9B | 5.9B | 100% |
Annual Yield % from dividends | 3.64 | 2.65 | 137% |
Returns for 1 year | 0.76 | -0.23 | -330% |
Returns for 3 years | 5.63 | 3.03 | 186% |
Returns for 5 years | -1.84 | -4.25 | 43% |
Returns for 10 years | 1.45 | -1.09 | -132% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HSLVX | 47.00 | 0.44 | +0.95% |
Hartford Small Cap Growth R6 | |||
EIHSX | 13.59 | 0.07 | +0.52% |
Eaton Vance Worldwide Health Sci I | |||
MALOX | 19.96 | 0.02 | +0.10% |
BlackRock Global Allocation Instl | |||
AIEVX | 24.79 | -0.08 | -0.32% |
Invesco EQV International Equity R5 | |||
JOMMX | 15.12 | -0.13 | -0.85% |
JOHCM Emerging Mkts Discovery Instl |